References
- Adams, S. S., Bough, R. G., Cliffe, E. E., Lessel, B., and Mills, R. F. N. 1969. Absorption, distri-bution and toxicity of ibuprofen. Toxicol. AppL PharmacoL 15:310–330.
- Babad, H., and Zeiler, A. G. 1973. The chemistry of phosgene. Chem. Rev. 73(1):75–91.
- Brown, J. E., and Birky, M. M. 1980. Phosgene in the thermal decomposition products of poly(vinyl chloride): Generation, detection and measurement./ Anal. Toxicol. 4:166-174. Brown, K. A., and Collins, A. J. 1977. Action of non-steroid anti-inflammatory drugs on human and rat peripheral leukocyte migration in vitro. Ann. Rheum. Dis. 36:239–243.
- Buege, J. A., and Aust, S. D. 1978. Microsomal lipid peroxidation. Methods Enzymol. 51:302–310.
- Callender, T. J., Morrow, L., Subramanian, K., Duhon, D., and Ristovy, M. 1993. Three-dimensional brain metabolic imaging in patients with toxic encephalopathy. Environ. Res. 60:295–319.
- Chan, P. K., O'Hara, G. P., and Hayes, A. W. 1989. Principles and methods for acute and subchronic toxicity. In Principles and methods of toxicology, edited by W. A. Haynes. New York: Raven Press.
- Currie, W. D., Hatch, G. E., and Frosolono, M. F. 1987. Changes in lung ATP concentration in the rat after low-level phosgene exposure.]. Biochem. Toxicol. 2:105–114.
- De Biasi, A., Sbraccia, M., Keizer, J., Testai, E., and Vitozzi, L. 1992. The regioselective binding of CHCI3 metabolites to microsomal phospholipids. Chem. Biol. Interact. 85:229–242.
- Diller, W. F. 1978. Medical problems and their solutions./ Occup. Med. 20(3):189–193.
- Frosolono, M. F., and Currie, W. D. 1985. Response of the pulmonary surfactant system to phosgene. Toxicol. Ind. Health 1(2):29–35.
- Ghio, A. J., Kennedy, T. P., Hatch, G. E., and Tepper, J. S. 1991. Reduction of neutrophil influx diminishes lung injury and mortality following phosgene inhalation. J. AppL PhysioL 71(2):657–665.
- Gilchrist, H. L. 1933. The residual effects of warfare gases: The use of phosgene gas, with reports of cases. Med. Bull. Veterans Admin. 10(1):4–36.
- Guo, Y.-L., Kennedy, T. P., Michael, J. R., Sciuto, A. M., Ghio, A. J., Adkinson, N. F., and Gurtner, G. H. 1990. Mechanisms of phosgene-induced lung injury: Role of arachidonate mediators./ AppL PhysioL 69(5):1615–1622.
- Halliwell, B., and Gutteridge, J. M. C. 1986. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts. Arch. Biochem. Biophys. 246(2):501–514.
- Jaskot, R. H., Grose, E. C., Richards, J. H., and Doerfler, D. L. 1991. Effects of inhaled phos-gene on rat lung anitoxidant systems. Fundam.AppL Toxicol. 17:666–674.
- Kahn, H. A. 1983. Introduction to epidemiologic methods. New York: Oxford University Press.
- Kennedy, T. P., Michael, J. R., Hoidal, J., Hasty, D., Sciuto, A. M., Hopkins, C. Lazar, R., Bysani, G. G., and Gurtner, G. H. 1989. Dibutyryl cAMP, aminophylline and 8-adrenergic agonists protect against pulmonary edema caused by phosgene.]. AppL PhysioL 67(6):2542–2552.
- Kennedy, T. P., Rao, N. V., Noah, W., Michael, J. R., Jafri, M., Gurtner, G. H., and Hoidal, J. 1990. Ibuprofen prevents oxidant lung injury and in vitro lipid peroxidation by chelating iron./ Clin. Invest. 86:1565–1573.
- Lehnert, B. E., Archuleta, D., Gurley, L. R., Session, W., Behr, M. J., Lehnert, N. M., and Stavert, D. M. 1995. Exercise potentiation of lung injury following inhalation of a pneu-moedematogenic gas: Perfluoroisobutylene. Exp. Lung Res. 21:331–350.
- Lindenschmidt, R., Patterson, C. E., Forney R. B., and Rhodes, R. A. 1983. Selective action of prostaglandin F2c, during paraquat-induced pulmonary edema in the perfused lung. ToxicoL Appl. PharmacoL 70:105–114.
- Lowry, 0. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with Folin phenol reagent./ BioL Chem. 193: 265–275.
- Moore, S., and Gates, M. 1946. Phosgene. In Chemical warfare agents and related chemical prob-lems, vol. I, pp. 17–23. Washington, DC.
- National Institute for Occupational Health and Safety. 1976. Criteria for a Recommended Standard: Occupational Exposure to Phosgene. U.S. Department of Health, Education, and Welfare, Public Health Service, CDC publication 76137. Washington, DC.
- Orzalesi, G., Selleri, R., Caldini, 0., Volpato, I., Innocenti, F., Colome, J., Sacristan, A., and Varez, D. 1977. Ibuproxam and ibuprofen: A pharmacological comparison. Arzneim.-Forsch./Drug Res. 27(5):1006–1012.
- Passmore, J. C., and Jimenez, A. E. 1993. Effectiveness of dual cyclooxygenase and leukotriene blockade with ibuprofen and LY203647 buring canine endotoxic shock. Circ. Shock 39:21–28.
- Pawlowski, R., and Frosolono, M. F. 1977. Effect of phosgene on rat lung after a single high-level exposure II. Ultrastructural alterations. Arch. Environ. Health 32:278–283.
- Pohl, L. R., and Krishna, G. 1978. Deuterium isotope effect in bioactivation and hepatotoxicity of chloroform. Life Sci. 23:1067–1072.
- Polednak, A. P., and Hollis, D. R. 1985. Mortality and cause of death among workers exposed to phosgene in 1943-45. Toxicol. Ind. Health 1(2):137–147.
- Sciuto, A. M., Strickland, P. T., Kennedy, T. P., and Gurtner, G. H. 1995. Protective effects of N-acetylcysteine treatment after phosgene exposure in rabbits. Am.]. Respir. Crit. Care Med. 151:768–772.
- Sciuto, A. M., Strickland, P. T., Kennedy, T. P., Guo, Y.-L., and Gurtner, G. H. 1996a. Intratracheal administration of dibutyryl cAMP attenuates edema formation in phosgene-induced acute lung injury./ Appl. PhysioL 80:149–157.
- Sciuto, A. M., Stotts, R. R., and Hurt, H. H. 1996b. The efficacy of ibuprofen and pentoxifylline in the treatment of phosgene-induced acute lung injury.]. Appl. Toxicol. 16(5):381-384. Sedlak, J., and Lindsay, R. H. 1968. Estimation of total, protein bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 25:192–205.
- Shinozawa, Y., Hales, C., Jung, W., and Burke, J. 1986. Ibuprofen prevents synthetic smoke-induced pulmonary edema. Am. Rev. Respir. Dis. 134:1145–1148.
- Stewart, R. J., Yamaguchi, K. T., Knost, P. M., Mason, S. W., Roshdieh, B. B., Samadani, S. and Chang, B. L. 1990. Effects of ibuprofen on pulmonary oedema in an animal smoke model. Burns 16(6):409–413.
- Uchiyama, M., and Mihara, M. 1978. Determination of malondialdehyde precursors in tissue by thiobarbituric acid test. Anal. Biochem. 86:271–278.
- Urbanetti, J. S. 1989. Phosgene: Clinical importance and management. Proc. Workshop on Acute Lung Injury and Pulmonary Edema (AD A216293), Aberdeen Proving Ground, MD, May, pp. 105–119.
- Utsunomiya, T., Krausz, M. M., Dunham, B., Valeri, C. R., Levine, L., Shepro, D., and Hechtman, H. B. 1982. Modification of inflammatory response to aspiration with ibuprofen. Am.]. PhysioL 243 (Heart Circ. Physiol 12):H903–H910.
- Werrlein, R. J., Madren-Whalley, J. S., and Kirby, S. D. 1994. Phosgene effects of F-actin organi-zation and concentration in cells cultured from sheep and rat lung. Cell BioL ToxicoL 10:45–58.
- Wise, W. C., Cook, J. A., Eller, T., and Halushka, P. V. 1980. Ibuprofen improves survival from endotoxic shock in the rat./ PharmacoL Exp. Ther. 215:160–164.
- Wong, S. H. Y., Knight, J. A., Hopfer, S. M., Zaharia, 0., Leach, C. N., and Sunderman, F. W. 1982. lipoperoxides in plasma as measured by liquid chromatographic separation of malon-dialdehyde-thiobarbituric acid adduct. Clin. Chem. 33(2):214–220.